Skip to main content
Year archive

Alvotech Holdings S.A — 2022 filings

All 209 regulatory filings released by Alvotech Holdings S.A (ALVO) in 2022, sourced directly from the official regulator.

209 Filings
2022 Period
2022 filings (209)
Filing Released Lang
424B3
Regulatory Filings
2022-12-22 English
424B3
Regulatory Filings
2022-12-22 English
6-K
Regulatory Filings
2022-12-22 English
Staða umsókna Alvotech um markaðsleyfi í Bandaríkjunum fyrir AVT02, útskiptilega líftæknilyfjahliðstæðu við Humira
Regulatory Filings
2022-12-22 Icelandic
Update on U.S. Regulatory Status of AVT02, Alvotech's Proposed High-Concentration, Interchangeable Biosimilar to Humira®
Regulatory Filings
2022-12-22 English
Alvotech Annex B Total Voting Rights (004).pdf - Adobe Acrobat
Declaration of Voting Results & Voting Rights Announcements
2022-12-21 English
424B3
Regulatory Filings
2022-12-16 English
424B3
Regulatory Filings
2022-12-16 English
6-K
Regulatory Filings
2022-12-16 English
Correction to Total Amount in Announcement About Private Placement Published 2022-12-16 09:00 GMT
Capital/Financing Update
2022-12-16 Icelandic
Correction to Total Amount in Announcement About Private Placement Published 2022-12-16 09:00 GMT
Capital/Financing Update
2022-12-16 English
Alvotech gengur frá um 8,5 milljarða króna skuldabréfafjármögnun
Capital/Financing Update
2022-12-16 Icelandic
Alvotech Completes $59.7 Million Private Placement
Capital/Financing Update
2022-12-16 English
Alvotech - Home Member State Notification (20221208)
Regulatory Filings
2022-12-09 English
424B3
Regulatory Filings
2022-12-08 English
424B3
Regulatory Filings
2022-12-08 English
6-K
Regulatory Filings
2022-12-08 English
Alvotech Shares Start Trading on Nasdaq Iceland Main Market
Delisting Announcement
2022-12-08 Icelandic
Alvotech Shares Start Trading on Nasdaq Iceland Main Market
Delisting Announcement
2022-12-08 English
Alvotech og STADA auka aðgengi sjúklinga að Hukyndra® (adalimumab) í Evrópu
Regulatory Filings
2022-12-07 Icelandic
Alvotech and STADA Broaden Access to Hukyndra® adalimumab biosimilar in Europe
Regulatory Filings
2022-12-07 English
Alvotech birtir skráningarlýsingu í tengslum við flutning á Aðalmarkað Nasdaq Iceland
Regulatory Filings
2022-12-06 Icelandic
Alvotech publishes prospectus related to the admission to trading and listing on Nasdaq Iceland Main Market
Share Issue/Capital Change
2022-12-06 English
Nasdaq Iceland Approves the Request for Trading of Alvotech's Shares on the Main Market
Regulatory Filings
2022-12-02 Icelandic
Nasdaq Iceland Approves the Request for Trading of Alvotech's Shares on the Main Market
Delisting Announcement
2022-12-02 English
424B3
Regulatory Filings
2022-12-01 English
424B3
Regulatory Filings
2022-12-01 English
6-K
Regulatory Filings
2022-12-01 English
Alvotech gerir breytingar á yfirstjórn fyrirtækisins
Board/Management Information
2022-12-01 Icelandic
Alvotech Announces Changes to its Leadership Team
Board/Management Information
2022-12-01 English
Alvotech: Restricted share unit agreements
Share Issue/Capital Change
2022-12-01 English
Alvotech Submits its Application for Admission of the Company's Shares to Trading on Nasdaq Iceland Main Market
Regulatory Filings
2022-11-30 Icelandic
Alvotech Submits its Application for Admission of the Company's Shares to Trading on Nasdaq Iceland Main Market
Regulatory Filings
2022-11-30 English
AMENDMENT NO. 2 TO SCHEDULE 13D
Major Shareholding Notification
2022-11-18 English
424B3
Regulatory Filings
2022-11-17 English
424B3
Regulatory Filings
2022-11-17 English
6-K
Regulatory Filings
2022-11-17 English
Alvotech tryggir aðgengi að um 20 milljarða króna fjármögnun
Capital/Financing Update
2022-11-16 Icelandic
Alvotech Secures Financing Facilities of Approximately $136 Million
Capital/Financing Update
2022-11-16 English
6-K
Regulatory Filings
2022-11-16 English
Alvotech Reports Financial Results for First Nine Months of 2022 And Provides Business Update
Earnings Release 9M 2022
2022-11-16 Icelandic
Alvotech Reports Financial Results for First Nine Months of 2022 And Provides Business Update
Earnings Release 9M 2022
2022-11-16 English
Alvotech Announces Australian Marketing Authorization for AVT02, a Biosimilar to Humira®
Regulatory Filings
2022-11-14 Icelandic
Alvotech Announces Australian Marketing Authorization for AVT02, a Biosimilar to Humira®
Regulatory Filings
2022-11-14 English
Alvotech to Present Switching Study Data for AVT02, a Proposed Biosimilar to Humira®, at 2022 American College of Rheumatology Conference
Regulatory Filings
2022-11-10 Icelandic
Alvotech to Present Switching Study Data for AVT02, a Proposed Biosimilar to Humira®, at 2022 American College of Rheumatology Conference
Regulatory Filings
2022-11-10 English
6-K
Regulatory Filings
2022-10-27 English
Alvotech mun birta uppgjör fyrir fyrstu níu mánuði ársins 2022 þann 15. nóvember og heldur kynningarfund 16. nóvember
Report Publication Announcement
2022-10-27 Icelandic
Alvotech to Report First Nine Months Financial Results on November 15, 2022 and Host Business Update Conference Call at 8:00 am ET on November 16, 2022
Report Publication Announcement
2022-10-27 English
Alvotech to Participate in Upcoming Jefferies London Healthcare Conference in November
Regulatory Filings
2022-10-26 Icelandic
Alvotech to Participate in Upcoming Jefferies London Healthcare Conference in November
Report Publication Announcement
2022-10-26 English
424B3
Regulatory Filings
2022-10-19 English
424B3
Regulatory Filings
2022-10-19 English
6-K
Regulatory Filings
2022-10-19 English
Alvotech and JAMP Pharma Expand Exclusive Partnership Adding Two Biosimilar Candidates for Canadian Market, Bringing New Options for Patients in Specialty Care
Regulatory Filings
2022-10-19 Icelandic
Alvotech and JAMP Pharma Expand Exclusive Partnership Adding Two Biosimilar Candidates for Canadian Market, Bringing New Options for Patients in Specialty Care
Regulatory Filings
2022-10-19 English
424B3
Regulatory Filings
2022-10-17 English
424B3
Regulatory Filings
2022-10-17 English
FORM 6-K
Regulatory Filings
2022-10-17 English
Alvotech's Partner Submits Application for Marketing Approval of First Biosimilar Candidate in Japan
Regulatory Filings
2022-10-17 Icelandic
Alvotech's Partner Submits Application for Marketing Approval of First Biosimilar Candidate in Japan
Earnings Release FY 2024
2022-10-17 English
424B3
Regulatory Filings
2022-10-12 English
424B3
Regulatory Filings
2022-10-12 English
6-K
Regulatory Filings
2022-10-12 English
Sarah Tanksley ráðin framkvæmdastjóri gæðaeftirlits hjá Alvotech
Board/Management Information
2022-10-11 Icelandic
Alvotech Appoints Sarah Tanksley as Chief Quality Officer
Board/Management Information
2022-10-11 English
Signed Share Purchase Declaration.pdf
Director's Dealing
2022-09-27 English
Alvotech S.A. Transactions of Managers and Closely Associated Persons
Director's Dealing
2022-09-27 English
424B3
Regulatory Filings
2022-09-23 English
424B3
Regulatory Filings
2022-09-23 English
6-K
Regulatory Filings
2022-09-23 English
Alvotech and STADA Increase Access to Adalimumab for Patients in Switzerland with the Launch of Hukyndra®
Regulatory Filings
2022-09-22 Icelandic
Alvotech and STADA Increase Access to Adalimumab for Patients in Switzerland with the Launch of Hukyndra®
Legal Proceedings Report
2022-09-22 English
Regulatory Filings 2022
Regulatory Filings
2022-09-22 English
Regulatory Filings 2022
Regulatory Filings
2022-09-22 English
424B3
Regulatory Filings
2022-09-21 English
424B3
Regulatory Filings
2022-09-21 English
Regulatory Filings 2022
Regulatory Filings
2022-09-19 English
Regulatory Filings 2022
Regulatory Filings
2022-09-19 English
F-1/A
Regulatory Filings
2022-09-14 English
Filing of Amendment No. 1 to Preliminary Prospectus on Form F-1 with U.S. Securities and Exchange Commission
Capital/Financing Update
2022-09-14 English
Alvotech - Resale F-1 As Filed 09.13.2022.pdf
Transaction in Own Shares
2022-09-14 English
Filing of Amendment No. 2 to Preliminary Prospectus on Form F-1 with U.S. Securities and Exchange Commission
Capital/Financing Update
2022-09-14 English
F-1/A
Regulatory Filings
2022-09-13 English
6-K
Regulatory Filings
2022-09-06 English
Alvotech birtir nýjar upplýsingar um stöðu upprunalegu leyfisumsóknarinnar fyrir AVT02 í Bandaríkjunum
Regulatory Filings
2022-09-05 Icelandic
Alvotech Reports Update on Initial AVT02 Biologics License Application
Regulatory Filings
2022-09-05 English
Alvotech Reports Update on Initial AVT02 Biologics License Application
Legal Proceedings Report
2022-09-05 Icelandic
Alvotech Reports Update on Initial AVT02 Biologics License Application
Legal Proceedings Report
2022-09-05 English
6-K
Regulatory Filings
2022-08-31 English
Alvotech - Q2 2022 MDA.pdf
Management Reports
2022-08-31 English
Alvotech Unaudited Condensed Consolidated Interim Financial Statements Q2 2022.pdf
Interim / Quarterly Report H1 2022
2022-08-31 English
Alvotech kynnir uppgjör fyrir fyrstu sex mánuði ársins 2022 og skýrir frá helstu áföngum frá áramótum
Report Publication Announcement
2022-08-31 Icelandic
Alvotech - Q2 2022 MDA.pdf
Management Reports
2022-08-31 English
Alvotech Unaudited Condensed Consolidated Interim Financial Statements Q2 2022.pdf
Interim / Quarterly Report H1 2022
2022-08-31 English
Alvotech Reports First Half 2022 Financial Results and Business Update
Interim / Quarterly Report H1 2022
2022-08-31 English
6-K
Regulatory Filings
2022-08-29 English
Alvotech Announces Corporate Sustainability Participation and Discloses ESG Data covering 2020 and 2021
Environmental & Social Information
2022-08-29 Icelandic
Alvotech Announces Corporate Sustainability Participation and Discloses ESG Data covering 2020 and 2021
Environmental & Social Information
2022-08-29 English
6-K
Regulatory Filings
2022-08-25 English
Alvotech hefur klíníska rannsókn á AVT03, fyrirhugaðri líftæknilyfjahliðstæðu við Prolia® og Xgeva®
Regulatory Filings
2022-08-25 Icelandic
Alvotech Initiates Confirmatory Patient Study for AVT03, a Proposed Biosimilar for Prolia® and Xgeva®
Regulatory Filings
2022-08-25 English
Alvotech to Participate in Two Upcoming Investor Conferences in September 2022
Regulatory Filings
2022-08-24 Icelandic
Alvotech to Participate in Two Upcoming Investor Conferences in September 2022
Report Publication Announcement
2022-08-24 English
S-8 as filed with SEC August 15 2022.pdf
Regulatory Filings
2022-08-16 English
Filing of Registration Statement on Form S-8 with the U.S. Securities and Exchange Commission
Report Publication Announcement
2022-08-16 English
S-8
Regulatory Filings
2022-08-15 English
Alvotech to Report First Six Months and Second Quarter 2022 Financial Results on August 31, 2022 and Host Business Update Conference Call at 8:00 am ET on September 1, 2022
Report Publication Announcement
2022-08-15 English
6-K
Regulatory Filings
2022-08-15 English
Alvotech mun birta uppgjör fyrir fyrsta árshelming og annan ársfjórðung 2022 þann 31. ágúst og heldur kynningarfund 1. september
Report Publication Announcement
2022-08-15 Icelandic
Alvotech to Report First Six Months and Second Quarter 2022 Financial Results on August 31, 2022 and Host Business Update Conference Call at 8:00 am ET on September 1, 2022
Report Publication Announcement
2022-08-15 English
Alvotech to Report First Six Months and Second Quarter 2022 Financial Results on August 31, 2022 and Host Business Update Conference Call at 8:00 am ET on September 1, 2022
Report Publication Announcement
2022-08-15 Icelandic
6-K
Regulatory Filings
2022-08-12 English
Stjórn Alvotech samþykkir áætlun um að undirbúa skráningu á Aðalmarkað Nasdaq á Íslandi
Share Issue/Capital Change
2022-08-12 Icelandic
Alvotech's Board of Directors Approves Plan to Prepare for Listing on Nasdaq Main Market in Iceland
Share Issue/Capital Change
2022-08-12 English
Alvotech's Board of Directors Approves Plan to Prepare for Listing on Nasdaq Main Market in Iceland
Regulatory Filings
2022-08-12 Icelandic
Alvotech's Board of Directors Approves Plan to Prepare for Listing on Nasdaq Main Market in Iceland
Regulatory Filings
2022-08-12 English
F-1A as filed with SEC July 27 2022.pdf
Regulatory Filings
2022-07-28 English
Filing of Amendment to Preliminary Prospectus on Form F-1 with U.S. Securities and Exchange Commission
Capital/Financing Update
2022-07-28 English
Filing of Amendment to Preliminary Prospectus on Form F-1 with U.S. Securities and Exchange Commission
Capital/Financing Update
2022-07-28 English
Regulatory Filings 2022
Regulatory Filings
2022-07-27 English
F-1/A
Regulatory Filings
2022-07-27 English
Regulatory Filings 2022
Regulatory Filings
2022-07-27 English
F-1 as filed with SEC July 22 2022 946432ACL.pdf
Regulatory Filings
2022-07-22 English
Filing of Preliminary Prospectus on Form F-1 with U.S. Securities and Exchange Commission
Capital/Financing Update
2022-07-22 English
F-1
Regulatory Filings
2022-07-22 English
Regulatory Filings 2022
Regulatory Filings
2022-07-22 English
6-K
Regulatory Filings
2022-07-20 English
Alvotech Initiates a Pharmacokinetic Study for AVT03, a Proposed Biosimilar for Prolia® and Xgeva®
Regulatory Filings
2022-07-20 Icelandic
Alvotech Initiates a Pharmacokinetic Study for AVT03, a Proposed Biosimilar for Prolia® and Xgeva®
Regulatory Filings
2022-07-20 English
SC 13D/A
Major Shareholding Notification
2022-07-18 English
FORM 6-K
Regulatory Filings
2022-07-18 English
AMENDMENT NO. 1 TO SCHEDULE 13D
Major Shareholding Notification
2022-07-15 English
Filing of Preliminary Prospectus on Form F-1 with U.S. Securities and Exchange Commission
Capital/Financing Update
2022-07-15 English
F-1
Regulatory Filings
2022-07-14 English
Alvotech fjölgar stjórnarmönnum við skráningu á markað
Board/Management Information
2022-07-14 Icelandic
Alvotech Expands its Board of Directors as part of Transition from Private to Publicly Traded Company
Board/Management Information
2022-07-14 English
FORM 6-K
Regulatory Filings
2022-07-14 English
Managers Transaction Notification 20220712.pdf
Director's Dealing
2022-07-13 English
Transactions of managers and closely associated persons
Director's Dealing
2022-07-13 English
Aztiq and Alvogen subscribe to shares in Alvotech at listing price of $10 per share
Share Issue/Capital Change
2022-07-13 English
Transactions of managers and closely associated persons
Director's Dealing
2022-07-13 English
Alvotech hefur klíníska rannsókn á AVT06, fyrirhugaðri líftæknilyfjahliðstæðu við Eylea®
Regulatory Filings
2022-07-07 Icelandic
Alvotech Initiates Patient Study for AVT06, a Proposed Biosimilar for Eylea®
Regulatory Filings
2022-07-07 English
Alvotech Initiates Patient Study for AVT06, a Proposed Biosimilar for Eylea®  
Regulatory Filings
2022-07-07 Icelandic
Alvotech Initiates Patient Study for AVT06, a Proposed Biosimilar for Eylea®  
Regulatory Filings
2022-07-07 English
6-K
Regulatory Filings
2022-07-07 English
6-K
Regulatory Filings
2022-07-05 English
Increase of share capital and creation of treasury share pool to meet obligations with respect to Warrants issued by Alvotech, the Management Incentive Plan, as well as option to issue shares pursuant
Share Issue/Capital Change
2022-07-05 English
SC 13D
Major Shareholding Notification
2022-07-02 English
SCHEDULE 13D
Major Shareholding Notification
2022-06-27 English
6-K
Regulatory Filings
2022-06-23 English
6-K
Regulatory Filings
2022-06-23 English
Viðauki við Skráningarskjal
Regulatory Filings
2022-06-23 Icelandic
Supplement to the Company Description
Report Publication Announcement
2022-06-23 English
20-F
Annual Report FY 2022
2022-06-22 English
SC 13G
Major Shareholding Notification
2022-06-22 English
6-K
Regulatory Filings
2022-06-21 English
Publication of a Company Description and Intended Listing on First North Iceland
Share Issue/Capital Change
2022-06-21 English
Birting skráningarskjals vegna fyrirhugaðrar skráningar á First North Iceland
Share Issue/Capital Change
2022-06-21 Icelandic
Birting skráningarskjals vegna fyrirhugaðrar skráningar á First North Iceland
Report Publication Announcement
2022-06-21 Icelandic
Regulatory Filings 2022
Regulatory Filings
2022-06-15 English
6-K
Regulatory Filings
2022-06-15 English
8-A12B
Regulatory Filings
2022-06-13 English
425 Filing
Regulatory Filings
2022-06-09 English
425 Filing
Regulatory Filings
2022-06-07 English
425 Filing
Regulatory Filings
2022-06-03 English
425 Filing
Regulatory Filings
2022-05-31 English
425 Filing
Regulatory Filings
2022-05-24 English
Regulatory Filings 2022
Regulatory Filings
2022-05-17 English
425 Filing
Regulatory Filings
2022-05-17 English
425 Filing
Regulatory Filings
2022-05-16 English
Regulatory Filings 2022
Regulatory Filings
2022-05-11 English
425 Filing
Regulatory Filings
2022-05-11 English
424B3
Regulatory Filings
2022-05-10 English
Regulatory Filings 2022
Regulatory Filings
2022-05-10 English
Regulatory Filings 2022
Regulatory Filings
2022-05-10 English
F-4/A
Regulatory Filings
2022-05-10 English
Regulatory Filings 2022
Regulatory Filings
2022-05-09 English
Regulatory Filings 2022
Regulatory Filings
2022-05-02 English
Regulatory Filings 2022
Regulatory Filings
2022-05-02 English
F-4/A
Regulatory Filings
2022-05-02 English
Regulatory Filings 2022
Regulatory Filings
2022-04-28 English
425 Filing
Regulatory Filings
2022-04-22 English
Regulatory Filings 2022
Regulatory Filings
2022-04-19 English
F-4/A
Regulatory Filings
2022-04-19 English
425 Filing
Regulatory Filings
2022-04-19 English
425 Filing
Regulatory Filings
2022-04-18 English
Regulatory Filings 2022
Regulatory Filings
2022-04-12 English
425 Filing
Regulatory Filings
2022-04-06 English
Regulatory Filings 2022
Regulatory Filings
2022-04-04 English
F-4/A
Regulatory Filings
2022-04-04 English
Regulatory Filings 2022
Regulatory Filings
2022-03-30 English
425 Filing
Regulatory Filings
2022-03-23 English
425 Filing
Regulatory Filings
2022-03-23 English
Regulatory Filings 2022
Regulatory Filings
2022-03-14 English
F-4/A
Regulatory Filings
2022-03-14 English
425 Filing
Regulatory Filings
2022-03-08 English
425 Filing
Regulatory Filings
2022-02-28 English
Regulatory Filings 2022
Regulatory Filings
2022-02-25 English
425 Filing
Regulatory Filings
2022-02-23 English
425 Filing
Regulatory Filings
2022-02-15 English
Regulatory Filings 2022
Regulatory Filings
2022-02-05 English
F-4/A
Regulatory Filings
2022-02-05 English
425 Filing
Regulatory Filings
2022-02-02 English
Regulatory Filings 2022
Regulatory Filings
2022-01-25 English
Regulatory Filings 2022
Regulatory Filings
2022-01-18 English
425 Filing
Regulatory Filings
2022-01-18 English
425 Filing
Regulatory Filings
2022-01-10 English